{"title":"Treating Alcohol Use Disorder in Patients with Alcohol Associated Liver Disease.","authors":"C. Tarli, A. Mirijello, G. Addolorato","doi":"10.1055/a-1798-2872","DOIUrl":null,"url":null,"abstract":"Alcohol use disorder (AUD) is one of the main causes of global death and disability. The liver represents the main target of alcohol damage and alcohol associated liver disease (ALD) represents the first cause of liver cirrhosis in Western Countries. Alcohol abstinence is the main goal of treatment in AUD patients with ALD, because treatments for ALD are less effective when drinking continues. Moreover, the persistence of alcohol consumption is associated with higher mortality, increased need for liver transplantation and graft loss. The most effective treatment for AUD is the combination of psychosocial interventions, pharmacological therapy and medical management. However, the effectiveness of these treatments in patients with ALD are doubtful even because AUD patients with ALD are usually excluded from pharmacological trials due to concerns on liver safety. This narrative review will discuss the treatment options for AUD-ALD patients focusing on controversies in pharmacological therapy.","PeriodicalId":21724,"journal":{"name":"Seminars in liver disease","volume":"11 1","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in liver disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-1798-2872","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 4
Abstract
Alcohol use disorder (AUD) is one of the main causes of global death and disability. The liver represents the main target of alcohol damage and alcohol associated liver disease (ALD) represents the first cause of liver cirrhosis in Western Countries. Alcohol abstinence is the main goal of treatment in AUD patients with ALD, because treatments for ALD are less effective when drinking continues. Moreover, the persistence of alcohol consumption is associated with higher mortality, increased need for liver transplantation and graft loss. The most effective treatment for AUD is the combination of psychosocial interventions, pharmacological therapy and medical management. However, the effectiveness of these treatments in patients with ALD are doubtful even because AUD patients with ALD are usually excluded from pharmacological trials due to concerns on liver safety. This narrative review will discuss the treatment options for AUD-ALD patients focusing on controversies in pharmacological therapy.
期刊介绍:
Seminars in Liver Disease is a quarterly review journal that publishes issues related to the specialties of hepatology and gastroenterology.
As the premiere review journal in the field, Seminars in Liver Disease provides in-depth coverage with articles and issues focusing on topics such as cirrhosis, transplantation, vascular and coagulation disorders, cytokines, hepatitis B & C, Nonalcoholic Steatosis Syndromes (NASH), pediatric liver diseases, hepatic stem cells, porphyrias as well as a myriad of other diseases related to the liver. Attention is also given to the latest developments in drug therapy along with treatment and current management techniques. Seminars in Liver Disease publishes commissioned reviews. Unsolicited reviews of an exceptional nature or original articles presenting remarkable results will be considered, but case reports will not be published.